Jabra Enhance Pro 20 at Costco vs Otofonix Groove

The Jabra Enhance Pro 20 at Costco is a prescription behind-the-ear hearing aid available for $1,600, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This places it in the top 61% of the 36 prescription hearing aids we've evaluated. In our testing, this device shows a mixed performance profile. Own-voice comfort is a clear strength, scoring 3.5/5—0.75 points above the category average—making it a solid choice for users who prioritize natural sound quality when speaking. Feedback handling is excellent at 4.8/5, slightly above the category average, indicating stable performance during typical daily activities. However, speech-in-noise performance is notably limited, scoring just 1.1/5—0.82 points below the category average of 1.96. This is a meaningful weakness for users who frequently encounter noisy environments like restaurants or social gatherings. Speech in quiet is solid at 3.2/5, though slightly below the category average. Music streaming scores 2.8/5, above average but only mixed in absolute terms. At this price point, buyers should consider alternatives. The Rexton Reach R-Li T80 at Costco scores 4.58/5 in the same price range, while lower-priced options like the Lexie B3 (4.76/5) offer stronger overall performance. The Jabra Enhance Pro 20 may suit users who prioritize own-voice comfort and feedback stability over challenging listening environments, but those needing robust noise handling should explore other options.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.